Pain Management Flashcards
7 cards from real PSA practice questions. Tap to flip, then mark Knew It or Still Learning โ missed cards come back until you master them.
Read the first 7 Pain Management flashcards as text
A patient with postherpetic neuralgia has failed a trial of amitriptyline. What is the most appropriate next step?
Answer: Gabapentin or pregabalin
Gabapentin and pregabalin are NICE-recommended alternatives for neuropathic pain when first-line agents fail.
Duloxetine is most appropriate for which pain condition?
Answer: Diabetic peripheral neuropathic pain
Duloxetine, an SNRI, is licensed and NICE-recommended for diabetic peripheral neuropathic pain.
A cancer patient on regular modified-release morphine reports breakthrough pain. How should PRN morphine be administered?
Answer: As needed, up to every 4 hours
Breakthrough (PRN) morphine can be administered as needed, typically up to every 4 hours, in addition to the background modified-release dose.
Which topical agent is licensed for localized peripheral neuropathic pain such as postherpetic neuralgia?
Answer: Lidocaine 5% medicated plaster
Lidocaine 5% medicated plasters are licensed for localized neuropathic pain, particularly postherpetic neuralgia.
A patient with metastatic bone pain from prostate cancer remains in pain despite regular paracetamol. Which adjuvant is most appropriate to add?
Answer: Dexamethasone 4 mg OD
Corticosteroids such as dexamethasone reduce peri-tumoral oedema and inflammation, providing effective adjuvant analgesia for bone metastases.
A 30-year-old woman with chronic widespread pain is prescribed amitriptyline 10 mg at night. What is the primary analgesic rationale?
Answer: As a low-dose adjuvant analgesic for central sensitization
Low-dose amitriptyline is used as an adjuvant analgesic, modulating descending pain pathways independently of its antidepressant effect.
A patient with multiple sclerosis has spasticity causing significant pain. Which medication directly targets this mechanism?
Answer: Baclofen 10 mg TDS
Baclofen is a GABA-B agonist that reduces spinal cord excitability, directly reducing spasticity and associated pain.